BT-474-luc Orthotopic Model

Synonyms: BT474

BT-474-luc is a luminescent breast cancer cell line derived from the BT-474 model. This cell line overexpresses human epidermal growth factor receptor 2 (HER2) and exhibits luminescence due to the introduction of the luciferase gene. It serves as a valuable tool for studying HER2-positive breast cancer and evaluating therapeutic interventions. BT-474-luc allows for non-invasive monitoring of tumor growth and response to treatment using bioluminescence imaging techniques. Researchers utilize this model to investigate HER2 signaling, test targeted therapies, and assess drug efficacy in preclinical studies.

Model Details

Cancer Type: Breast Cancer
Model Name: BT-474-luc
Mouse Strain: Rag1 KO
Treatment Data Available: N/A

BT-474-luc Survival

Survival of BT-474-luc after intracranial injection in Rag1 KO mice (n=5)

Request Additional Syngeneic Model Data

Contact Us

Get Started.

Have questions about how TD2 can assist with your regulatory needs? Reach out to our
expert staff today to get started.

Skip to content